AP1M2 expression levels in BLCA, BRCA, and COAD (all P < 0.0001) were all significantly and negatively related to B cells, T cells (CD4+ and CD8+), macrophages, neutrophils, and DC. This evidence concerns the gene AP1M2 and colon adenocarcinoma.